一夜之间,Web3 成了背景板,Web4 带着算力和市值汹涌登场。 OpenClaw 冲上 GitHub 顶流,AI 概念股持续失控上涨。在焦虑情绪中,AI Agent 经济已经成了加密世界绕不开的主线。有人在部署“龙虾 Agent”,让它做助理、做分析师、做合伙人;有人在科技巨头裁员名单里刷新邮箱,开始认真思考一个问题: 如果 AI 可以替我决策、替我交易、替我执行,那我干什么? 当 AI 开始...
一夜之间,Web3 成了背景板,Web4 带着算力和市值汹涌登场。 OpenClaw 冲上 GitHub 顶流,AI 概念股持续失控上涨。在焦虑情绪中,AI Agent 经济已经成了加密世界绕不开的主线。有人在部署“龙虾 Agent”,让它做助理、做分析师、做合伙人;有人在科技巨头裁员名单里刷新邮箱,开始认真思考一个问题: 如果 AI 可以替我决策、替我交易、替我执行,那我干什么? 当 AI 开始决策,经济主体的定义就被改写。人类曾经是唯一拥有账户、拥有信用、拥有货币使用权的物种,而现在,机器正在申请入场。 问题还剩一个——它用什么钱?银行不为 AI 开户,信用卡不为算法设计,信用体系为人类设计。对 AI 来说,钱不是财富,而是接口,不是价值储存,是执行逻辑的路径。 答案就在谜面之中,属于 AI 的货币,是区块链上的稳定币。 当 AI 需要在全球范围内无许可交易、即时清算、低成本协作时,稳定币不再是币圈资产,而有机会成为 AI 全球经济体系的“最佳美元 API”。 当 AI 成为世界经济的一份子:为什么 AI 需要 Crypto? 当 Manus 被 Meta 以超 20 亿美元收购,当人人都在领养属于自己的一只“OpenClaw 龙虾”,和 3 年前的 AI 世界相比,AI Agent 正在以远超以往想象的速度渗透到人类生活的方方面面。甚至,宽泛意义上来说,过年期间阿里旗下千问的“免单下单活动”也可以被视为 AI Agent 的经典范例。 大人,时代变了 当 AI 不只是工具,而需要进行决策与执行,甚至成为经济体,“让 AI 花钱”这件事,实际上远比常人想象的更为复杂。 具体而言,让 AI 花钱至少需要回答以下 4 个问题: 1. 你是谁? 2. 你有什么钱? 3. 你如何付钱? 4. 谁控制你花钱? 放到现实世界和互联网体系,每一个问题都有很高的现实门槛;但 Crypto 的代币机制、技术协议和去中心化、无许可原则给了 AI Agent 不一样的解决方案—— AI 没有身份?ERC-8004 标准给你一整套身份系统,链上身份注册、声誉评分、验证机制一应俱全。据 8004scan.io网站信息,目前 AI Agent 注册数量已接近 50000 个。 AI Agent 没有银行账户?链上钱包就是最方便快捷的存钱罐,稳定币就是流动性最好的“链上法币”。对于 AI 来...
2011年,美国经典情景喜剧《好汉两个半》(Two and a Half Men)宣布了一项重大决定:新生代男演员阿什顿·库彻(Ashton Kutcher)将取代参演了前八季所有剧集的查理·辛(Charlie Sheen)成为新的男主角——对于制作方来说,这已经是个最优解,因为查理·辛曝出吸毒丑闻身陷囹圄,已经绝无洗白可能。而阿什顿·库彻高大帅气、阳光健康,是所有新生代男演员里最有喜剧天赋的那一...
2011年,美国经典情景喜剧《好汉两个半》(Two and a Half Men)宣布了一项重大决定:新生代男演员阿什顿·库彻(Ashton Kutcher)将取代参演了前八季所有剧集的查理·辛(Charlie Sheen)成为新的男主角——对于制作方来说,这已经是个最优解,因为查理·辛曝出吸毒丑闻身陷囹圄,已经绝无洗白可能。而阿什顿·库彻高大帅气、阳光健康,是所有新生代男演员里最有喜剧天赋的那一个,也是所有喜剧演员里最有偶像派潜力的那一个。 而从后面的结果来看,制作方也确实押对了宝。阿什顿·库彻成为主角的第九季第一集收获了2870万观众,创造了《好汉两个半》开播以来的最高收视纪录。2012年播出的《好汉两个半》第十季因此备受期待,吸引了大量广告主参与,成为了该剧集播放以来最赚钱的一季,单集收入超过300万美元。2013年,阿什顿·库彻通过在传记电影《乔布斯传》中饰演乔布斯,一举成为好莱坞最炙手可热的年轻演员。 但在当时,核心剧迷们其实提出了强烈的反对。他们的理由是,《好汉两个半》的灵魂就在于,剧中的两位男主角分别是“声色犬马的富豪”与“离异带娃的屌丝”。这两种人设在现实生活中理应完全没有交集,但编剧用“亲兄弟”的设定让两人强行生活在一起。“家族亲情”和老牌资本主义社会的“私产至上”文化交织在一起,制造出了大量的地狱笑话,非常带劲。相比之下,库彻太阳光太健康,一看就没有吃过生活的苦,还有八块腹肌。 于是本着“笑果”不打折扣、降低解释成本的前提,编剧们给库彻设计了这样一个同样有着强烈共识的人设: 他饰演的角色是一位硅谷幸运儿,千禧年代开始创业,年纪轻轻就通过把产品卖给了大公司成为了亿万富翁,一切来得太顺太简单,于是人生进入了一种物质上衣食无忧但精神无比空洞的状态,需要不断通过酒精、恋爱来找乐子 。 而我们今天故事的主角,几乎就是这个角色的翻版:他同样千禧年代创业,瞄准IT,29岁的时候就成功地把技术方案卖给了微软,赚到了第一桶金;38岁那年,苹果正式用3.6亿美元买下了他的公司,彻底实现财富自由并在当年被大量媒体评为“四十岁以下最杰出的创业者之一”——套用上面那个经典群体形象,等待他的将是花天酒地、纸醉金迷,或者像彼得·蒂尔那样投身到哲学或者意识形态领域当中,用全新的世界观来对抗虚无。 可当他再次出现在公众视野中时,人们却看到了这样一条故事线:从苹果赚到3.6亿美元之...
Putin Decries 'Cynical Murder' Of His Friend Ayatollah Khamenei Russian President Vladimir Putin in Sunday comments blasted the United States and Israel's "cynical" assassination of Ayatollah Khamenei which happened the day prior in the opening salvo of the US-Israeli Operation Epic Fury. Other translations in European media have used the word "murder" - citing Putin. He expressed condolences to t...
Putin Decries 'Cynical Murder' Of His Friend Ayatollah Khamenei Russian President Vladimir Putin in Sunday comments blasted the United States and Israel's "cynical" assassination of Ayatollah Khamenei which happened the day prior in the opening salvo of the US-Israeli Operation Epic Fury. Other translations in European media have used the word "murder" - citing Putin. He expressed condolences to the Islamic Republic: "Please accept my deepest condolences in connection with the assassination of the supreme leader of the Islamic Republic of Iran... committed in cynical violation of all norms of human morality and international law," Putin said in a message to Iranian President Masoud Pezeshkian. "In our country, Ayatollah Khamenei will be remembered as an outstanding statesman who made a tremendous personal contribution to the development of friendly Russian-Iranian relations ," he added. Clearly the two 'pariah's' (in the West's labeling) always enjoyed warm, friendly relations. via AP Putin had met with Khamenei directly on several occasions in the past . The Kremlin has further confirmed Monday that it remains in close communication with authorities in Tehran, after dozens of top leaders and officers have been killed in the massive bombing raids. "We are in constant contact with the leadership of Iran and are discussing the situation surrounding that country," spokesman Dmitry Peskov told reporters at a briefing. The Russian spokesman said it was "deep disappointment" that Oman-brokered nuclear negotiations, the last of which were in Geneva, "deteriorated to the point of outright aggression." Down to the eve of the bombing of Tehran, the Iranian side was giving 'positive' signals of 'progress'. But they once again feel duped, also amid reports the Iran operation had already been planned for weeks. But Moscow's priority still remains balancing and improving delicate relations with Washington amid the grinding, over four year long Ukraine 'special military operation'...
Earnings Call Insights: Zymeworks Inc. (ZYME) Q4 2025 Management View Kenneth Galbraith, Chairman, CEO, Acting CFO & President, opened by highlighting the Phase III HERIZON-GEA-01 trial results: "Zanidatamab in combination with chemotherapy with or without a checkpoint inhibitor demonstrated a median PFS exceeding one year with a median overall survival exceeding 2 years in the first-line metastat...
Earnings Call Insights: Zymeworks Inc. (ZYME) Q4 2025 Management View Kenneth Galbraith, Chairman, CEO, Acting CFO & President, opened by highlighting the Phase III HERIZON-GEA-01 trial results: "Zanidatamab in combination with chemotherapy with or without a checkpoint inhibitor demonstrated a median PFS exceeding one year with a median overall survival exceeding 2 years in the first-line metastatic or locally advanced HER2-positive GEA patients." He emphasized the consistent benefit across subgroups and the potential to redefine the treatment paradigm for HER2-positive metastatic or locally advanced GEA. Galbraith stated that Jazz expects to complete the supplemental BLA submission with the FDA in the first quarter of 2026 and that Zymeworks anticipates zanidatamab approval and launch in the second half of the year, subject to FDA review. He also noted, "These partnerships allowed us to accelerate the development of zanidatamab and broaden the therapeutic potential in many other HER2-expressing tumors while sharing development risk and transferring cost to our partners." The company reported regulatory approvals for zanidatamab as monotherapy in both Canada and the UK for second-line biliary tract cancer and is eligible for up to $440 million in global regulatory milestone payments for GEA, plus an additional $89 million for approval in a third indication. Zymeworks remains eligible for up to $977.5 million in commercial milestone payments. The company announced a $250 million royalty-backed note financing with Royalty Pharma, structured to securitize only 30% of the Ziihera royalty stream until repaid, preserving 70% of ongoing cash flows. Galbraith explained, "This framework uses both continued share repurchases and potential strategic acquisitions to compound predictable revenues into durable long-term shareholder value." Bijal Desai, SVP of Finance, stated, "Total revenue was $106 million for 2025 compared to $76.3 million for 2024. The increase for the year wa...